Evolving Care Strategies

Evolving Care Strategies in Newly Diagnosed HL: Emerging Therapies and the Changing Role of the Oncology Nurse
Evolving Care Strategies in Newly Diagnosed HL: Emerging Therapies and the Changing Role of the Oncology Nurse
CNE
Amy L. Goodrich, RN, MSN, CRNP; Mollie E. Moran, MSN, CNP, AOCNP
Release Date: December 06, 2018
Expiration Date: December 06, 2019
New and emerging therapies are changing the treatment paradigms and care of patients with newly diagnosed advanced Hodgkin lymphoma. This symposium replay takes a closer look at these changes and their impact to nursing care. Our presenters provide an overview of the therapeutic treatment options and their known side-effect profiles which, if left unmanaged, could impact the overall progress and quality of life for patients. This activity includes presentations from our expert faculty on best strategies to employ in recognizing, treating, and long-term management of adverse events. We encourage you to listen in as faculty discuss the day-to-day educational needs of patients being treated for cHL.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Seattle Genetics, Inc.
Begin, Earn CreditView Only, No Credit
 

Managing HL would like to recognize and thank Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics for their educational support of ManagingHodgkinLymphoma.com in 2018.

©2018 MediCom Worldwide, Inc. All rights reserved